🔎 Trials Near Me

Početna › Akutna bifentipska leukemija › Georgia

Kliničke studije za Akutna bifentipska leukemija u državi Georgia

9 studija za Akutna bifentipska leukemija traži sudionike na lokacijama u državi Georgia.

Gradovi u državi Georgia

Službeni tekst studije (engleski)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • Emory University, Atlanta
U tijeku regrutacijaFaza 1
Od 12 do 78 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
U tijeku regrutacijaFaza 2
365 Days · Oba spola · Ažurirano 25. ruj 2026. · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Emory Winship Cancer Institute, Atlanta
U tijeku regrutacijaFaza 1/2
30 Days · Oba spola · Ažurirano 16. ruj 2026. · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Augusta University Medical Center, Augusta
  • Atrium Health Navicent, Macon
  • i još 1
U tijeku regrutacijaFaza 3
365 Days – 25 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
U tijeku regrutacijaFaza 1/2
Do 22 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04726241

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  • Children's Healthcare of Atlanta, Atlanta
U tijeku regrutacijaFaza 1
Od 1 do 30 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06177067

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
U tijeku regrutacijaFaza 1
Od 1 do 40 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT05292664

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
U tijeku regrutacijaFaza 1
Od 12 godina i više · Oba spola · Ažurirano 8. sij 2026. · NCT04872478

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Healthcare of Atlanta, Emory University, Atlanta
U tijeku regrutacijaFaza 1
Od 1 do 21 godina · Oba spola · Ažurirano 6. pro 2024. · NCT05476770

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.